Home
  • The World's Top 10 Most Innovative Companies in Healthcare

    February 13, 2014 – For creating a built-in pain-relief platform. Some of the most chronic diseases--such as rheumatoid arthritis, diabetes, and multiple sclerosis--are due to some form of inflammation. SetPoint's technology consists of a tiny implant in the vagus nerve of the neck that, when activated, helps reduce the inflammatory reflex--the physiological response that controls inflammation--via a pathway discovered by the company's cofounder. SetPoint Medical, whose aim is to offer cheaper and less risky therapies for inflammatory diseases, is currently involved in clinical trials.
    Read More
     
  • SetPoint Medical Named One of the "Fierce 15" Leading Medical Technology Companies of 2013

    Valencia, CA. – October 15, 2013 – SetPoint Medical, a biomedical technology company developing neuromodulation therapies for inflammatory diseases, announced today that it has been named by FierceMedicalDevices as one of 2013's Fierce 15 device and diagnostic companies, designating it as one of the most promising private companies in the med tech space. This is FierceMedicalDevices’ second annual Fierce 15 selection.
    Read More
     
  • SetPoint Medical Secures $27 Million Financing

    Valencia, CA. – August 8, 2013 – SetPoint Medical, a biomedical technology company developing neuromodulation therapies for inflammatory diseases, announced today that it has secured $27 million in financing from its current investors along with new investors Covidien Ventures, Action Potential Venture Capital Limited, the new GlaxoSmithKline (GSK) strategic venture capital fund for bioelectronic medicines and technologies, and Boston Scientific.
    Read More
     
  • GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies

    GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases.
    Read More
     

Get To Know The Management

Anthony Arnold
CEO
Mike Faltys
CTO
Ralph Zitnik, MD
CMO
Allan Will
Chairman
 

S5 Box

Login

Register

*
*
*
*
*
*

Fields marked with an asterisk (*) are required.